in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cambrex reports fall in profits
7:35 AM MST | November 6, 2012 | Deepti Ramesh
Cambrex (East Rutherford, NJ) reported a 39% fall in net profits for the third quarter, ended 30 September 2012, compared with the year-ago period, to $1.68 million. Net sales increased 2.7%, to $59.4 million, primarily because of higher custom development revenues and higher volumes of generic active pharmaceutical ingredients (APIs) partially offset by lower pricing, Cambrex says. “We had a strong quarter as sales increased across virtually all of our product categories, with record quarterly cash flow, and excellent working capital results,” says...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee